ИНТЕГРАЛЬНЫЙ ПОДХОД К ОЦЕНКЕ ВЗАИМОСВЯЗИ ИЗМЕНЕНИЙ ПОКАЗАТЕЛЕЙ ИММУННОГО СТАТУСА И МАРКЁРОВ НЕСПЕЦИФИЧЕСКОГО ВОСПАЛЕНИЯ ПРИ ИБС

We carried out a comprehensive evaluation of cellular and humoral immunity, nonspecific inflammation markers and their relationship to the thickness of the intima-media of the carotid arteries and the impact of changes in these parameters on the nature of coronary artery disease. The study included 44 patients with chronic forms of coronary artery disease and 35 healthy individuals. In patients with ischemic heart disease has changed mainly of innate immunity, such as the activation of NK-cells (CD16, CD 56), CD 4+CD25+, with regulatory activity in respect of the synthesis of pro- and — inflammatory and anti-inflammatory cytokines, as well as an increase in the level of antiphospholipid antibodies, CRP and the thickness of the complex of intima-media of the carotid arteries, the degree of change in the links of the immunity reflects the severity of the disease.

1. Аронов Д.М. Лечение и профилактика атеросклероза. М.: Триада Х. 2000. 412 с.

2. Климов А.Н., Нагорнев В.А., Денисенко А.Д. Изучение иммунологических механизмов развития атеросклероза и новые методы его диагностики и лечения // Мед. акад. ж. 2005. Т. 5. В. 2. С. 18–32.

3. Климов А.Н., Нагорнев В.А., Денисенко А.Д., Константинов В.О. Аутоиммунная теория патогенеза атеросклероза и новые пути его лечения // Вестник РАМН 2003. В. 12. С. 29–34.

4. Нагорнев В.А, Восканьяни А.Н. Атерогенез как иммуновоспалительный процесс // Вестник РАМН 2004. В. 7. С. 3–11.

5. Черний В.И., Нестеренко А.Н. Нарушения иммунитета при критических состояниях. Особенности диагностики // Внутренняя медицина. 2007. № 3.

6. Ярилин А.А. Иммунология. М.: Геотар-Медиа. 2010. 752 с.

7. Agrawal A., Cha Molstad H., Samols D., Kushner I. Overexpressed nuclear factor B can participate in endogenous C_reactive protein induction, and enhances the effect of C/EBPв and signal transducer and activator of transcription_3 // Immunology. 2003. Vol. 108. P. 539–547.

8. Aukrust P., Otterdal K., Yndestad A., Sandberg W.J., Smith C., Ueland T., Øie E., Damås J.K., Gullestad L., Halvorsen B. The complex role of T-cellbased immunity in atherosclerosis // Curr. Atheroscler. Rep. 2008. Vol. 10. P. 236–243.

9. Biasucci L.M., Liuzzo G., Fantuzzi G. et al. Increasing levels of Interleukin-1 Ra and Interleukin-6 during the first two days of hospitalisation in unstable angina are associated with increased risk of in-hospital

10. coronary events // Circulation. 1999. Vol. 99. P. 2079–2084.

11. Cheng X., Yu X., Ding Y.J, Fu Q.Q., Xie J.J., Tang T.T. et al. The Th17/Treg imbalance in patients with acute coronary syndrome // Clin. Immunol. 2008. Vol. 127. P. 89–97.

12. Erlinger T., Platz E., Rifai N., Helzlsouer K. C-reactive protein and the risk of incident colorectal cancer. C_reactive protein and the risk of incident colorectal cancer // JAMA. 2004. Vol. 291, № 5. P. 585–590.

13. Gotsman I., Gupta R., Lichtman A.H. The influence of the regulatory T lymphocytes on atherosclerosis // Arterioscler. Thromb Vasc. Biol. 2007. Vol. 27. P. 2493–1495.

14. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease // N. Engl. J. Med. 2005. Vol. 352. P. 1685–1695.

15. Hansson G.K., Libby P. The immune response in atherosclerosis: A double-edged sword // Nat. Rev. Immunol. 2006. Vol. 6. P. 508–519.

16. Khreiss T., Jo’zsef L., Potempa L., Filep J. Conformational Rearrangement in C-Reactive Protein Is Required for Proinflammatory Actions on Human Endothelial Cells // Circulation. 2004. Vol. 109. P. 2016–2022.